One day of estradiol treatment enhances platelet aggregation at the site of microvascular injury without altering aggregation ex vivo

William I. Rosenblum, Farouk El-Sabban, Guy H. Nelson

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Mice were implanted subcutaneously with a pellet containing 0.5 mg estradiol placebo. On the day following implantation platelet aggregation was produced in arterioles on the brain surface (pial arterioles) by injuring their endothelium in vivo with a noxious light/dye stimulus. The time between the onset of the noxious stimulus and the appearance of platelet aggregates was significantly shortened (p<.01) in the estradiol treated mice. In contrast to this enhancement of aggregation, when platelets were tested ex vivo in platelet rich plasma (PRP), aggregation to sodium arachidonate or to ADP was not altered in estradiol treated mice. Thus the enhanced aggregation observed in injured pial arterioles of estradiol treated mice may not reflect direct effects of estradiol on the platelet itself. Rather enhanced aggregation may reflect an effect of estradiol on endothelium or adjacent tissue. This effect was produced within 24 hours of achieving pregnancy levels of estradiol. The rapidity of the effect is of interest in light of earlier studies showing a similar in vivo action following 7-14 days of high estradiol levels. The rapid effect suggests that an action on megakaryocytes is an unlikely explanation for the results.

Original languageEnglish
Pages (from-to)123-128
Number of pages6
JournalLife Sciences
Volume42
Issue number2
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Dive into the research topics of 'One day of estradiol treatment enhances platelet aggregation at the site of microvascular injury without altering aggregation ex vivo'. Together they form a unique fingerprint.

Cite this